Single intradiscal injection of the interleukin-6 receptor antibody tocilizumab provides short-term relief of discogenic low back pain; prospective comparative cohort study

Journal of Orthopaedic Science

Volumn 21, Issue 1, 2016, Pages 2-6

  Sainoh, Takeshi ^a   Orita, Sumihisa ^a   Miyagi, Masayuki ^b   Inoue, Gen ^b   Yamauchi, Kazuyo ^a   Suzuki, Miyako ^a   Sakuma, Yoshihiro ^a   Kubota, Go ^a   Oikawa, Yasuhiro ^a   Inage, Kazuhide ^a   Sato, Jun ^a   Nakata, Yukio ^a   Aoki, Yasuchika ^c   Takahashi, Kazuhisa ^a   Ohtori, Seiji ^a  

^a CHIBA UNIVERSITY   (Japan)

^b KITASATO UNIVERSITY   (Japan)

^c Eastern Chiba Medical Center   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIBIOTIC AGENT; BUPIVACAINE; LIDOCAINE; TOCILIZUMAB; INTERLEUKIN 6 RECEPTOR; MONOCLONAL ANTIBODY;

ADULT; AGED; ANALGESIA; ARTICLE; CLINICAL ARTICLE; COHORT ANALYSIS; COMPARATIVE STUDY; CONTROLLED STUDY; DISCOGENIC PAIN; DISKITIS; DISKOGRAPHY; DRUG EFFICACY; DRUG SAFETY; FEMALE; HUMAN; INTERVERTEBRAL DISK DEGENERATION; LOW BACK PAIN; MALE; NUCLEAR MAGNETIC RESONANCE IMAGING; OSWESTRY DISABILITY INDEX; PAIN ASSESSMENT; PROSPECTIVE STUDY; COMPLICATION; CONTROLLED CLINICAL TRIAL; IMMUNOLOGY; INTERVERTEBRAL DISK; INTRALESIONAL DRUG ADMINISTRATION; MIDDLE AGED; VERY ELDERLY; YOUNG ADULT;

ADULT; AGED; AGED, 80 AND OVER; ANTIBODIES, MONOCLONAL, HUMANIZED; COHORT STUDIES; FEMALE; HUMANS; INJECTIONS, INTRALESIONAL; INTERVERTEBRAL DISC; INTERVERTEBRAL DISC DEGENERATION; LOW BACK PAIN; MALE; MIDDLE AGED; PROSPECTIVE STUDIES; RECEPTORS, INTERLEUKIN-6; YOUNG ADULT;

EID: 84989811221     PISSN: 09492658     EISSN: 14362023     Source Type: Journal    
DOI: 10.1016/j.jos.2015.10.005     Document Type: Article

References (30)

1. [1] Airaksinen, O., Brox, J.I., Cedraschi, C., Hildebrandt, J., Klaber-Moffett, J., Kovacs, F., Mannion, A.F., Seis, S., Staal, J.B., Ursin, H., Zanoli, G., COST B13 Working Group on Guidelines for Chronic Low Back Pain. Chapter 4. European guidelines for the management of chronic nonspecific low back pain. Eur Spine J 15:Suppl. 2 (2006), S192–S300.
2. [2] Schwarzer, A.C., Aprill, C.N., Derby, R., Fortin, J., Kine, G., Bogduk, N., The prevalence and clinical features of internal disc disruption in patients with chronic low back pain. Spine (Phila Pa 1976) 20 (1995), 1878–1883.
3. [3] Igarashi, A., Kikuchi, S., Konno, S., Olmarker, K., Inflammatory cytokines released from the facet joint tissue in degenerative lumbar spinal disorders. Spine (Phila Pa 1976) 29 (2004), 2091–2095.
4. [4] Freeman, M.D., Woodham, M.A., Woodham, A.W., The role of the lumbar multifidus in chronic low back pain: a review. PM R 2:2 (2010), 142–146.
5. [5] Freemont, A.J., Peacock, T.E., Goupille, P., Hoyland, J.A., O'Brien, J., Jayson, M.I., Nerve ingrowth into diseased intervertebral disc in chronic back pain. Lancet 350 (1997), 178–181.
6. [6] Ohtori, S., Inoue, G., Ito, T., Koshi, T., Ozawa, T., Doya, H., Saito, T., Moriya, H., Takahashi, K., Tumor necrosis factor-immunoreactive cells and PGP 9.5-immunoreactive nerve fibers in vertebral endplates of patients with discogenic low back pain and Modic Type 1 or Type 2 changes on MRI. Spine 31 (2006), 1026–1031.
7. [7] Lee, S., Moon, C.S., Sul, D., Lee, J., Bae, M., Hong, Y., Lee, M., Choi, S., Derby, R., Kim, B.J., Kim, J., Yoon, J.S., Wolfer, L., Kim, J., Wang, J., Hwang, S.W., Lee, S.H., Comparison of growth factor and cytokine expression in patients with degenerated disc disease and herniated nucleus pulposus. Clin Biochem 42 (2009), 1504–1511.
8. [8] Buttermann, G.R., The effect of spinal steroid injections for degenerative disc disease. Spine J 4 (2004), 495–505.
9. [9] Khot, A., Bowditch, M., Powell, J., Sharp, D., The use of intradiscal steroid therapy for lumbar spinal discogenic pain: a randomized controlled trial. Spine 29 (2004), 833–836.
10. [10] Cohen, S.P., Wenzell, D., Hurley, R.W., Kurihara, C., Buckenmaier, C.C. 3rd, Griffith, S., Larkin, T.M., Dahl, E., Morlando, B.J., A double-blind, placebo-controlled, dose-response pilot study evaluating intradiscal etanercept in patients with chronic discogenic low back pain or lumbosacral radiculopathy. Anesthesiology 107 (2007), 99–105.
11. [11] Mihara, M., Kasutani, K., Okazaki, M., Nakamura, A., Kawai, S., Sugimoto, M., Matsumoto, Y., Ohsugi, Y., Tocilizumab inhibits signal transduction mediated by both mIL-6R and sIL-6R, but not by the receptors of other members of IL-6 cytokine family. Int Immunopharmacol 5 (2005), 1731–1740.
12. [12] Nishimoto, N., Miyasaka, N., Yamamoto, K., Kawai, S., Takeuchi, T., Azuma, J., Kishimoto, T., Study of active controlled tocilizumab monotherapy for rheumatoid arthritis patients with an inadequate response to methotrexate (SATORI): significant reduction in disease activity and serum vascular endothelial growth factor by IL-6 receptor inhibition therapy. Mod Rheumatol 19 (2009), 12–19.
13. [13] Ohtori, S., Miyagi, M., Takahashi, K., Inoue, G., Orita, S., Ochiai, N., Kishida, S., Kuniyoshi, K., Nakamura, J., Aoki, Y., Ishikawa, T., Arai, G., Kamoda, H., Suzuki, M., Takaso, M., Furuya, T., Kubota, G., Sakuma, Y., Oikawa, Y., Toyone, T., Takahashi, K., Efficacy of epidural administration of anti-interleukin-6 receptor antibody onto spinal nerve for treatment of sciatica. Eur Spine J 21 (2012), 2079–2084.
14. [14] Pfirrmann, C.W., Metzdorf, A., Zanetti, M., Hodler, J., Boos, N., Magnetic resonance classification of lumbar intervertebral disc degeneration. Spine (Phila Pa 1976) 26 (2001), 1873–1878.
15. [15] Kim, S.H., Ahn, S.H., Cho, Y.W., Lee, D.G., Effect of intradiscal methylene blue injection for the chronic discogenic low back pain: one-year prospective follow-up study. Ann Rehabil Med 36 (2012), 657–664.
16. [16] Singh, K., Ledet, E., Carl, A., Intradiscal therapy: a review of current treatment modalities. Spine (Phila Pa 1976) 30 (2005), S20–S26.
17. [17] Smith, S.E., Darden, B.V., Rhyne, A.L., Wood, K.E., Outcome of unoperated discogram-positive low back pain. Spine (Phila Pa 1976) 20 (1995), 1997–2001.
18. [18] Manchikanti, L., Glaser, S.E., Wolfer, L., Derby, R., Cohen, S.P., Systematic review of lumbar discography as a diagnostic test for chronic low back pain. Pain Physician 12 (2009), 541–559.
19. [19] Ohtori, S., Kinoshita, T., Yamashita, M., Inoue, G., Yamauchi, K., Koshi, T., Suzuki, M., Orita, S., Eguchi, Y., Nakamura, S., Yamagata, M., Takaso, M., Ochiai, N., Kishida, S., Aoki, Y., Takahashi, K., Results of surgery for discogenic low back pain: a randomized study using discography versus discoblock for diagnosis. Spine (Phila Pa 1976) 34 (2009), 1345–1348.
20. [20] Hägg, O., Fritzell, P., Nordwall, A., The clinical importance of changes in outcome scores after treatment for chronic low back pain. Eur Spine J 12 (2003), 12–20.
21. [21] Deyo, R.A., Weinstein, J.N., Low back pain. N Engl J Med 344 (2001), 363–370.
22. [22] Mooney, V., Presidential address. International Society for the Study of the Lumbar Spine. Dallas, 1986. Where is the pain coming from?. Spine (Phila Pa 1976) 12 (1987), 754–759.
23. [23] Burke, J.G., Watson, R.W., McCormack, D., Dowling, F.E., Walsh, M.G., Fitzpatrick, J.M., Intervertebral discs which cause low back pain secrete high levels of proinflammatory mediators. J Bone J Surg Br 84 (2002), 196–201.
24. [24] Hashizume, M., Mihara, M., The roles of interleukin-6 in the pathogenesis of rheumatoid arthritis. Arthritis, 2011, 2011, 765624.
25. [25] Sharma, S.K., Jones, J.O., Zeballos, P.P., Irwin, S.A., Martin, T.W., The prevention of discitis during discography. Spine J 9 (2009), 936–943.
26. [26] Subach, B.R., Copay, A.G., Martin, M.M., Schuler, T.C., DeWolfe, D.S., Epidural abscess and cauda equina syndrome after percutaneous intradiscal therapy in degenerative lumbar disc disease. Spine J 12 (2012), e1–4.
27. [27] Miller, M.R., Mathews, R.S., Reeves, K.D., Treatment of painful advanced internal lumbar disc derangement with intradiscal injection of hypertonic dextrose. Pain Physician 9 (2006), 115–121.
28. [28] Lee, H., Sowa, G., Vo, N., Vadala, G., O'Connell, S., Studer, R., Kang, J., Effect of bupivacaine on intervertebral disc cell viability. Spine J 10 (2010), 159–166.
29. [29] Quero, L., Klawitter, M., Nerlich, A.G., Leonardi, M., Boos, N., Wuertz, K., Bupivacaine–the deadly friend of intervertebral disc cells?. Spine J 11 (2011), 46–53.
30. [30] Ohtori, S., Inoue, G., Orita, S., Eguchi, Y., Ochiai, N., Kishida, S., Kuniyoshi, K., Nakamura, J., Aoki, Y., Ishikawa, T., Miyagi, M., Kamoda, H., Suzuki, M., Takaso, M., Toyone, T., Kubota, G., Sakuma, Y., Oikawa, Y., Inage, K., Sainoh, T., Takahashi, K., No acceleration of intervertebral disc degeneration after a single injection of bupivacaine in young age group with follow-up of 5 years. Asian Spine J 7 (2013), 212–217.